Last updated 19 days ago

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

698 patients around the world

Available in Argentina, Chile, Mexico, United States, Brazil, Spain

AbbVie

13Research sites

698Patients around the world

This study is for people with

Lung cancer

Non-small cell lung carcinoma

Requirements for the patient

From 18 Years

All Gender

Medical requirements

Sites

Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro

Recruiting

25 de mayo 174, Viedma, Río Negrowww.imoviedma.com.ar

CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires

Av. Galvan 4102, CABA, Buenos Aireswww.cemic.edu.ar/

Hospital Británico de Buenos Aires - CABA

Recruiting

Perdriel 74, CABA, Buenos Aireshttps://www.hospitalbritanico.org.ar/

Centro Médico Austral OMI - CABA

Recruiting

Montevideo 955, C1019ABS Cdad. Autónoma de Buenos Aires, Argentina

Fundación CENIT para la Investigación en Neurociencias

Recruiting

Juncal 2222, C1125 CABA, Argentina

Instituto de Oncología Ángel H. Roffo - CABA, Buenos Aires

Av. San Martín 5481, CABA, Buenos Aires

Hospital de Câncer de Barretos - Fundação PIO XII

Recruiting

Rua Antenor Duarte Villela 1331 - Barretos, Sao Paulo, 14784-400

Instituto de Ensino e Pesquisa São Lucas

Recruiting

São Paulo, Sao Paulo, 01236-030

Instituto D'or de Pesquisa e Ensino - Rio de Janeiro

Recruiting

Rio de Janeiro, 22281-100

Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA

Recruiting

Pr. da Cruz Vermelha, 23 - Centro, Rio de Janeiro - RJ, 20230-130

Casa de Saúde Santa Marcelina

Recruiting

Rua Santa Marcelina, 177 - Itaquera - SP - CEP: 08270-070

Clínica AMO

Recruiting

Salvador, Bahia, 41830-907

Irmandade da Santa Casa de Misericórdia de Porto Alegre

Recruiting

Rua Professor Annes Dias - Centro Histórico, Porto Alegre - RS, 90020-090, Brazil

SponsorAbbVie

Study typeInterventional

Conditions

Non-small cell lung carcinomaLung cancer

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT04928846